✦ LIBER ✦

Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas

Book ID: 109835272
Publisher: Nature Publishing Group
Year: 1981
Tongue: English
Weight: 210 KB
Volume: 43
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1981.41

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress in ovarian cancer research: Pro

Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium

✍ M.L. DISIS; S.E. RIVKIN; A. BARON; M. MARKMAN; D. CONNOLLY; F. UELAND; E. KOHN; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Gynecomastia in testicular cancer patien

Gynecomastia in testicular cancer patients prognostic and therapeutic implications

✍ Alexander Tseng JR; Sandra J. Horning; Fuad S. Freiha; Kenneth J. Resser; John F 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

Eighty-one patients with advanced testicular cancer were evaluated for gynecomastia or severe breast tenderness at diagnosis and after platinum-based chemotherapy. The prognostic significance of gynecomastia in these two settings was explored. At presentation, 10% (8 patients) had gynecomastia or br

Progress in ovarian cancer: an overview

Progress in ovarian cancer: an overview and perspective

✍ R.F. Ozols 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Ovarian cancer: progress and continuing

Ovarian cancer: progress and continuing controversies in management

✍ Charlotte Moss; Stan B Kaye 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Recent progress in the diagnosis and tre

Recent progress in the diagnosis and treatment of ovarian cancer

✍ Danijela Jelovac; Deborah K. Armstrong 📂 Article 📅 2011 🏛 American Cancer Society 🌐 English ⚖ 230 KB

Molecular pathogenesis and therapeutic t

Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer

✍ Jeremy R. Chien; Giovanni Aletti; Debra A. Bell; Gary L. Keeney; Viji Shridhar; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract Ovarian cancer, the most aggressive gynecologic cancer, is the foremost cause of death from gynecologic malignancies in the developed world. Two primary reasons explain its aggressive behavior: most patients present with advanced disease at diagnosis, and die of recurrences from disease